Skip to main content
IOVA logo
IOVA
(NASDAQ)
Iovance Biotherapeutics, Inc.
$3.54-- (--)
Loading... - Market loading

Iovance Biotherapeutics (IOVA) Stock Price & Financial Analysis

Iovance Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.48 - $3.65
52-Week High$5.63
52-Week Low$1.64
Open$3.48
Volume8.85M
Average Volume (3M)15.99M
Market Cap1.24B
Shares Outstanding357.35M
Price to Sales (P/S)4.69
Price to Book (P/B)1.77
EV/EBITDA-3.11
Revenue (TTM)263.50M
Net Income (TTM)-390.98M
Free Cash Flow (TTM)-336.24M
EPS (TTM)$-1.09
Profit Margin-148.38%
Operating Margin-153.08%
Return on Equity (ROE)-55.97%
Debt to Equity0.07
50-Day MA$3.80
200-Day MA$2.79
52-Week Change91.71%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Iovance Biotherapeutics

What is the current stock price for IOVA?

As of the latest trading session, IOVA stock trades at $3.54. The 52-week range is $1.64–$5.63, with a day range of $3.48–$3.65.

What is the P/E ratio for IOVA?

The P/E ratio (Price-to-Earnings) for IOVA is shown in the Key Statistics section. This valuation metric helps compare Iovance Biotherapeutics, Inc. to industry peers.

Does IOVA pay dividends?

Iovance Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IOVA?

Based on 4 analysts, the consensus for IOVA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IOVA?

Iovance Biotherapeutics's market capitalization is $1.27B, classifying it as a small-cap company..